Making inroads of radiotherapy in gallbladder cancer.
Autorzy:
Talapatra K; Department of Radiation Oncology, Nanavati Max Super Speciality Hospital, Mumbai, Maharashtra, India. Lewis S; Department of Radiotherapy and Oncology, Kasturba Medical College, Manipal, Karnataka, India.
Pokaż więcej
Źródło:
Indian journal of cancer [Indian J Cancer] 2023 Oct 01; Vol. 60 (4), pp. 447-448. Date of Electronic Publication: 2024 Jan 23.
Grossing and reporting of radical prostatectomy specimens: An evidence-based approach.
Autorzy:
Rao BV; Basavatarakam Indo American Cancer Hospital and Research Institute, Hyderabad, Telangana, India. Soni S; Muljibhai Patel Urological Hospital, Nadiad, Gujarat, India. Kulkarni B; Kokilaben Dhirubhai Ambani Hospital and Research Centre, Mumbai, Maharashtra, India. Bindhu MR; Amrita Institute of Medical Sciences, Kochi, Kerala, India. Ambekar A; Apollo Hospitals, Navi Mumbai, Maharashtra, India. Midha D; Tata Medical Centre Kolkata, West Bengal, India. Kaushal S; A.I.I.M.S, New Delhi, India. Patil S; Shri Siddhivinayak Ganapati Cancer Hospital, Miraj, Maharashtra, India. Jagdale R; Shri Siddhivinayak Ganapati Cancer Hospital, Miraj, Maharashtra, India. Sundaram S; Sri Ramachandra Institute of Higher Education and Research, Chennai, Tamil Nadu, India. Kumar RM; Christian Medical College, Vellore, Tamil Nadu, India. Desai S; Department of Pathology, Tata Medical Centre, Mumbai, Maharashtra, India. Menon S; Department of Pathology, Tata Medical Centre, Mumbai, Maharashtra, India.
Pokaż więcej
Źródło:
Indian journal of cancer [Indian J Cancer] 2023 Oct 01; Vol. 60 (4), pp. 449-457. Date of Electronic Publication: 2023 Apr 17.
CD47 expression in urothelial carcinoma and its correlation with histopathological findings.
Autorzy:
Çoban G; Department of Pathology, Bezmialem Vakif University, Faculty of Medicine, Istanbul, Turkey. Yıldız P; Department of Pathology, Bezmialem Vakif University, Faculty of Medicine, Istanbul, Turkey. Şahin N; Department of Pathology, Bezmialem Vakif University, Faculty of Medicine, Istanbul, Turkey. Ersöz C; Department of Urology, Bezmialem Vakif University, Faculty of Medicine, Istanbul, Turkey. Toprak A; Department of Biostatistics, Bezmialem Vakif University, Faculty of Medicine, Istanbul, Turkey. Ünver N; Department of Pathology, Yedikule Pulmonary Diseases and Thoracic Surgery Education and Research Hospital, Istanbul, Turkey. Elagöz Ş; Department of Pathology, Bezmialem Vakif University, Faculty of Medicine, Istanbul, Turkey.
Pokaż więcej
Źródło:
Indian journal of cancer [Indian J Cancer] 2023 Oct 01; Vol. 60 (4), pp. 458-463. Date of Electronic Publication: 2023 Nov 30.
Prevalence, distribution, and risk markers for the development of gonadal germ cell tumors in patients with certain types of disorders of sexual differentiation with Y chromosome - A retrospective study.
Autorzy:
Das DV; Department of Endocrinology, Government Medical College, Thiruvanathapuram, Kerala, India. Jabbar PK; Department of Endocrinology, Government Medical College, Thiruvanathapuram, Kerala, India. Gomez R; Department of Endocrinology, Government Medical College, Thiruvanathapuram, Kerala, India. Nambisan B; Department of Obstetrics and Gynecology, Government Medical College, Thiruvanathapuram, Kerala, India. Bhuvitha MS; Department of Pathology, Government Medical College, Thiruvanathapuram, Kerala, India. Nair A; Department of Endocrinology, Government Medical College, Thiruvanathapuram, Kerala, India. Jayakumari C; Department of Endocrinology, Government Medical College, Thiruvanathapuram, Kerala, India.
Pokaż więcej
Źródło:
Indian journal of cancer [Indian J Cancer] 2023 Oct 01; Vol. 60 (4), pp. 464-474. Date of Electronic Publication: 2023 Dec 06.
Survival outcomes of epithelial ovarian cancer treated at a tertiary-level hospital in India.
Autorzy:
Chandy RG; Department of Gynaecologic Oncology, Christian Medical College, Vellore, Tamil Nadu, India. Thomas V; Department of Gynaecologic Oncology, Christian Medical College, Vellore, Tamil Nadu, India. Sebastian A; Department of Gynaecologic Oncology, Christian Medical College, Vellore, Tamil Nadu, India. Mani T; Department of Biostatistics, Christian Medical College, Vellore, Tamil Nadu, India. Thomas A; Department of Gynaecologic Oncology, Christian Medical College, Vellore, Tamil Nadu, India. Joel A; Department of Medical Oncology, Christian Medical College, Vellore, Tamil Nadu, India. Ram TS; Department of Radiation Oncology, Christian Medical College, Vellore, Tamil Nadu, India. Peedicayil A; Department of Gynaecologic Oncology, Christian Medical College, Vellore, Tamil Nadu, India.
Pokaż więcej
Źródło:
Indian journal of cancer [Indian J Cancer] 2023 Oct 01; Vol. 60 (4), pp. 475-485. Date of Electronic Publication: 2024 Jan 03.
Bortezomib-based induction therapy followed by autologous hematopoietic cell transplantation in newly diagnosed multiple myeloma patients: A single-center experience and review of Indian literature.
Autorzy:
Kathrotiya M; Departments of Clinical Hematology and HCT, Tata Medical Center, Kolkata, West Bengal, India. Radhakrishnan V; Departments of Clinical Hematology and HCT, Tata Medical Center, Kolkata, West Bengal, India. Bhave SJ; Departments of Clinical Hematology and HCT, Tata Medical Center, Kolkata, West Bengal, India. Nag A; Departments of Clinical Hematology and HCT, Tata Medical Center, Kolkata, West Bengal, India. Arora N; Laboratory Hematology and Cytogenetics, Tata Medical Center, Kolkata, West Bengal, India. Roychoudhry M; Department of Clinical Hematology and HCT, Nursing Division, Tata Medical Center, Kolkata, West Bengal, India. Parihar M; Laboratory Hematology and Cytogenetics, Tata Medical Center, Kolkata, West Bengal, India. Mishra D; Laboratory Hematology and Cytogenetics, Tata Medical Center, Kolkata, West Bengal, India. Nair R; Departments of Clinical Hematology and HCT, Tata Medical Center, Kolkata, West Bengal, India. Chandy M; Departments of Clinical Hematology and HCT, Tata Medical Center, Kolkata, West Bengal, India. Kumar J; Departments of Clinical Hematology and HCT, Tata Medical Center, Kolkata, West Bengal, India.
Pokaż więcej
Źródło:
Indian journal of cancer [Indian J Cancer] 2023 Oct 01; Vol. 60 (4), pp. 486-492. Date of Electronic Publication: 2024 Jan 23.
2/1 dose schedule of sunitinib is superior than the 4/2 regimen for the first-line therapy of clear cell metastatic renal cell carcinoma - An Indian experience.
Autorzy:
Jaipuria J; Amity Centre for Cancer Epidemiology and Cancer Research, Amity Institute of Biotechnology, Amity University, Noida, Uttar Pradesh, India. Jain A; Uro-Oncology Division, Rajiv Gandhi Cancer Institute and Research Centre, Rohini, Sector - 5, New Delhi, India. Gupta S; Uro-Oncology Division, Rajiv Gandhi Cancer Institute and Research Centre, Rohini, Sector - 5, New Delhi, India. Sadasukhi N; Uro-Oncology Division, Rajiv Gandhi Cancer Institute and Research Centre, Rohini, Sector - 5, New Delhi, India. Kasaraneni P; Uro-Oncology Division, Rajiv Gandhi Cancer Institute and Research Centre, Rohini, Sector - 5, New Delhi, India. Singh A; Uro-Oncology Division, Rajiv Gandhi Cancer Institute and Research Centre, Rohini, Sector - 5, New Delhi, India. Gupta K; Catalyst Clinical Services Pvt. Ltd., New Delhi, India. Sharma G; Amity Centre for Cancer Epidemiology and Cancer Research, Amity Institute of Biotechnology, Amity University, Noida, Uttar Pradesh, India. Talwar V; Medical Oncology Division, Rajiv Gandhi Cancer Institute and Research Centre, Rohini, Sector - 5, New Delhi, India. Rawal SK; Uro-Oncology Division, Rajiv Gandhi Cancer Institute and Research Centre, Rohini, Sector - 5, New Delhi, India.
Pokaż więcej
Źródło:
Indian journal of cancer [Indian J Cancer] 2023 Oct 01; Vol. 60 (4), pp. 493-500. Date of Electronic Publication: 2024 Jan 09.
A Phase III open-label randomized study to compare the efficacy of lenalidomide-rituximab with bendamustine-rituximab in treatment-naïve follicular lymphoma.
Autorzy:
Paikaray SK; All India Institute of Medical Sciences, New Delhi, India. Gogia A; Department of Medical Oncology, All India Institute of Medical Sciences, New Delhi, India. Kumar L; Department of Medical Oncology, All India Institute of Medical Sciences, New Delhi, India. Sharma A; Department of Medical Oncology, All India Institute of Medical Sciences, New Delhi, India. Biswas AA; Department of Radiation Oncology, All India Institute of Medical Sciences, AIIMS, New Delhi, India. Vishnubhatla S; Department of Biostatistics, AIIMS, New Delhi, India. Mallick S; Department of Pathology, All India Institute of Medical Sciences, New Delhi, India.
Pokaż więcej
Źródło:
Indian journal of cancer [Indian J Cancer] 2023 Oct 01; Vol. 60 (4), pp. 501-504. Date of Electronic Publication: 2024 Jan 04.
The different prognostic factors between metastatic and nonmetastatic disease of esophageal neuroendocrine carcinoma.
Autorzy:
Zhong L; Department of Medical Oncology, Huzhou Central Hospital, Affiliated Central Hospital HuZhou University, Zhejiang, China. Pan Y Han S Qi Q Liao H Jiang Y Shen J
Pokaż więcej
Źródło:
Indian journal of cancer [Indian J Cancer] 2023 Oct 01; Vol. 60 (4), pp. 512-520. Date of Electronic Publication: 2024 Jan 10.
Analysis of clinical profile and role of various prognostic factors in early bone marrow response in children with acute lymphoblastic leukemia treated by Modified Multicenter Protocol (MCP) 841 protocol: Experience from a tertiary care center in North India.
Autorzy:
Garg M; Department of Peadiatrics, PGIMS, Rohtak, Haryana, India. Abrol P; Department of Peadiatrics, PGIMS, Rohtak, Haryana, India. Gupta N; Department of Peadiatrics, PGIMS, Rohtak, Haryana, India. Bharti S; Department of Pathology, Govt. Medical College, Sector 32, Chandigarh, India. Nadda A; Department of Community Medicine, PGIMS, Rohtak, Haryana, India.
Pokaż więcej
Źródło:
Indian journal of cancer [Indian J Cancer] 2023 Oct 01; Vol. 60 (4), pp. 521-527. Date of Electronic Publication: 2024 Jan 23.
Quality of life and shoulder function among oral cancer patients treated with selective neck dissection: A cross-sectional study.
Autorzy:
Karthikeyan GR; Bharath Institute of Higher Education and Research, Chennai, Tamil Nadu, India.; Department of Oral and Maxillo-Facial Surgery, Karpaga Vinayaga Institute of Dental Sciences, GST Road, Chinnakolambakam, Palayanur (PO), Chengalpattu (District), Tamil Nadu, India. Venkatramanaiah C; Department of Anatomy, Bharath Medical College and Hospital, Chennai, Tamil Nadu, India. Balasubramaniyam B; Department of Oral and Maxillo-Facial Surgery, Karpaga Vinayaga Institute of Dental Sciences, GST Road, Chinnakolambakam, Palayanur (PO), Chengalpattu (District), Tamil Nadu, India. Aiyathurai M; Department of Oral and Maxillo-Facial Surgery, Karpaga Vinayaga Institute of Dental Sciences, GST Road, Chinnakolambakam, Palayanur (PO), Chengalpattu (District), Tamil Nadu, India. Velu D; Department of Oral and Maxillo-Facial Surgery, Karpaga Vinayaga Institute of Dental Sciences, GST Road, Chinnakolambakam, Palayanur (PO), Chengalpattu (District), Tamil Nadu, India. Indrapriyadharshini K; Public Health Dentistry, Karpaga Vinayaga Institute of Dental Sciences, GST Road, Chinnakolambakam, Palayanur (PO), Chengalpattu (District), Tamil Nadu, India.
Pokaż więcej
Źródło:
Indian journal of cancer [Indian J Cancer] 2023 Oct 01; Vol. 60 (4), pp. 528-533. Date of Electronic Publication: 2023 Mar 21.
Clinicopathologic features and risk factors associated with oral squamous cell carcinoma (OSCC): A comprehensive descriptive study analyzing the burden of OSCC in a tertiary-level hospital in North Kerala, India.
Autorzy:
Thankappan S; Department of Oral Medicine and Radiology, Govt. Dental College, Calicut, Kerala, India. Nedumpillil S; Department of Oral Pathology and Microbiology, Govt. Dental College, Calicut, Kerala, India. Thomas V; Department of Oral Medicine and Radiology, Govt. Dental College, Calicut, Kerala, India.
Pokaż więcej
Źródło:
Indian journal of cancer [Indian J Cancer] 2023 Oct 01; Vol. 60 (4), pp. 534-541. Date of Electronic Publication: 2024 Jan 09.
Association of preoperative serum adipokines, insulin, and sex steroid hormones with breast cancer risk in the Indian women.
Autorzy:
Dhiman D; Lady Hardinge Medical College, New Delhi, India.; Dr. Y.S. Parmar Govt. Medical College, Nahan, Himachal Pradesh, India. Kumar A; Institute of Biotechnology, HiLIFE, University of Helsinki, Finland. Shukla S; Lady Hardinge Medical College, New Delhi, India.
Pokaż więcej
Źródło:
Indian journal of cancer [Indian J Cancer] 2023 Oct 01; Vol. 60 (4), pp. 548-555. Date of Electronic Publication: 2024 Jan 09.
Synchronous occurrence of medullary and papillary thyroid cancer and survival rates.
Autorzy:
Akgun E; Department of Nuclear Medicine, Yuksek Ihtisas Hospital, Kirikkale, Turkey. Sager S; Department of Nuclear Medicine, Cerrahpasa Medical Faculty, Istanbul University-Cerrahpasa, Istanbul, Turkey. Beytur F; Department of Nuclear Medicine, Cerrahpasa Medical Faculty, Istanbul University-Cerrahpasa, Istanbul, Turkey. Nazari A; Department of Nuclear Medicine, Cerrahpasa Medical Faculty, Istanbul University-Cerrahpasa, Istanbul, Turkey. Ozturk T; Department of Pathology, Cerrahpasa Medical Faculty, Istanbul University-Cerrahpasa, Istanbul, Turkey. Teksoz S; Department of General Surgery, Cerrahpasa Medical Faculty, Istanbul University-Cerrahpasa, Istanbul, Turkey. Sonmezoglu K; Department of Nuclear Medicine, Cerrahpasa Medical Faculty, Istanbul University-Cerrahpasa, Istanbul, Turkey.
Pokaż więcej
Źródło:
Indian journal of cancer [Indian J Cancer] 2023 Oct 01; Vol. 60 (4), pp. 556-561. Date of Electronic Publication: 2023 Jun 09.
Apatinib plus drug-eluting bead transarterial chemoembolization as bridging therapy to surgical resection displays an acceptable efficacy and safety profile in hepatocellular carcinoma patients.
Autorzy:
Yan J; Department of Hepatobiliary Surgery, Shanxi Provincial People's Hospital, Taiyuan, China. Sun Y; Department of Interventional Radiology, Shanxi Provincial People's Hospital, Taiyuan, China. Fan D; Department of Hepatobiliary Surgery, Shanxi Provincial People's Hospital, Taiyuan, China. Mu W; Department of General Surgery, Shanxi Hospital of Integrated Traditional and Western Medicine, Taiyuan, China.
Pokaż więcej
Źródło:
Indian journal of cancer [Indian J Cancer] 2023 Oct 01; Vol. 60 (4), pp. 562-569. Date of Electronic Publication: 2024 Jan 23.
Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies